Literature DB >> 9660372

The case for conservative management of early HIV disease.

W J Burman1, R R Reves, D L Cohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9660372     DOI： 10.1001/jama.280.1.93

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Authors:  Adrian Levy; Karissa Johnston; Lieven Annemans; Andrea Tramarin; Julio Montaner
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  When should antiretroviral therapy for HIV be started?

Authors:  Andrew N Phillips; Brian G Gazzard; Nathan Clumeck; Marcelo H Losso; Jens D Lundgren
Journal:  BMJ       Date:  2007-01-13

3.  Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.

Authors:  Abdel G Babiker; Sean Emery; Gerd Fätkenheuer; Fred M Gordin; Birgit Grund; Jens D Lundgren; James D Neaton; Sarah L Pett; Andrew Phillips; Giota Touloumi; Michael J Vjechaj
Journal:  Clin Trials       Date:  2012-04-30       Impact factor: 2.486

Review 4.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

5.  Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.

Authors:  Angela Cescon; Sophie Patterson; Colin Davey; Erin Ding; Janet M Raboud; Keith Chan; Mona R Loutfy; Curtis Cooper; Ann N Burchell; Alexis K Palmer; Christos Tsoukas; Nima Machouf; Marina B Klein; Sean B Rourke; Anita Rachlis; Robert S Hogg; Julio S G Montaner
Journal:  J Int AIDS Soc       Date:  2015-10-05       Impact factor: 5.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.